DK248376A - Isoxazolderivater samt deres fremstilling og anvendelse - Google Patents
Isoxazolderivater samt deres fremstilling og anvendelseInfo
- Publication number
- DK248376A DK248376A DK248376A DK248376A DK248376A DK 248376 A DK248376 A DK 248376A DK 248376 A DK248376 A DK 248376A DK 248376 A DK248376 A DK 248376A DK 248376 A DK248376 A DK 248376A
- Authority
- DK
- Denmark
- Prior art keywords
- manufacture
- isoxazole derivatives
- isoxazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2524959 | 1975-06-05 | ||
| DE2524959A DE2524959C2 (de) | 1975-06-05 | 1975-06-05 | 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK248376A true DK248376A (da) | 1976-12-06 |
| DK151013B DK151013B (da) | 1987-10-12 |
| DK151013C DK151013C (da) | 1988-03-07 |
Family
ID=5948292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK248376A DK151013C (da) | 1975-06-05 | 1976-06-04 | Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4087535A (da) |
| JP (1) | JPS5938230B2 (da) |
| AT (1) | AT349007B (da) |
| BE (1) | BE842689A (da) |
| CA (1) | CA1076584A (da) |
| CH (1) | CH603608A5 (da) |
| DK (1) | DK151013C (da) |
| ES (1) | ES448386A1 (da) |
| FR (1) | FR2313052A1 (da) |
| GB (1) | GB1547452A (da) |
| IE (1) | IE43136B1 (da) |
| IT (1) | IT1063592B (da) |
| LU (1) | LU75077A1 (da) |
| MX (1) | MX3144E (da) |
| NL (1) | NL178596C (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2654797A1 (de) * | 1976-12-03 | 1978-06-08 | Hoechst Ag | Verfahren zur herstellung von isoxazolderivaten |
| JPS54102196U (da) * | 1977-12-28 | 1979-07-18 | ||
| DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
| EP0143142A3 (de) * | 1979-06-11 | 1985-07-17 | Ciba-Geigy Ag | Alphacarbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung |
| DE2940189A1 (de) * | 1979-10-04 | 1981-04-16 | Basf Ag, 6700 Ludwigshafen | Isoxazolylcarbonsaeureanilide, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| FR2538806B1 (fr) * | 1982-12-30 | 1986-02-21 | Bago Sa Labor | Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur |
| JPS6398092A (ja) * | 1986-10-14 | 1988-04-28 | 富士電機株式会社 | 金券用カ−ド残金精算装置 |
| US4935434A (en) * | 1988-01-26 | 1990-06-19 | Bristol-Myers Company | Antiarthritic isoxazole-4-carboxamides |
| DD297328A5 (de) | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
| US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
| US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| US5108999A (en) * | 1990-02-02 | 1992-04-28 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| DK0527736T3 (da) * | 1990-05-18 | 1997-10-20 | Hoechst Ag | Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler. |
| US6133301A (en) * | 1991-08-22 | 2000-10-17 | Aventis Pharma Deutschland Gmbh | Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
| DE4127737A1 (de) | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
| GB9320299D0 (en) * | 1993-10-01 | 1993-11-17 | Roussel Lab Ltd | Isoxazole derivatives |
| US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
| US6335356B1 (en) | 1994-01-07 | 2002-01-01 | Sugen, Inc. | Method of treating a patient by parenteral administration of a lipophilic compound |
| US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
| US5624946A (en) * | 1994-07-05 | 1997-04-29 | Williams; James | Use of leflunomide to control and reverse chronic allograft rejection |
| US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
| US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
| US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
| EP0903345B1 (de) * | 1997-08-08 | 2000-10-04 | Aventis Pharma Deutschland GmbH | Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid |
| US7691890B2 (en) | 1998-03-11 | 2010-04-06 | James W. Williams | Anti-viral uses of leflunomide products |
| US20050255071A1 (en) * | 1998-12-10 | 2005-11-17 | Aventis Pharma Deutschland Gmbh | Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors |
| GB0123571D0 (en) * | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| ATE396719T1 (de) | 2001-04-05 | 2008-06-15 | Aventis Pharma Inc | Verwendung von (z)-2-cyano-3-hydroxy-but-2- ensäure-(4'-trifluoromethylphenyl)-amid zur behandlung der multiplen sklerose |
| US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
| EP1675850B1 (en) * | 2003-09-12 | 2008-06-25 | Rigel Pharmaceuticals, Inc. | Quinoline compounds and their uses |
| EP1781637A1 (en) * | 2004-06-29 | 2007-05-09 | Rigel Pharmaceuticals, Inc. | 2-substituted quinoline compounds and their uses as inhibitors of the ige receptor signaling cascade |
| US20060024376A1 (en) * | 2004-07-30 | 2006-02-02 | The University Of Chicago | Methods and compositions for reducing toxicity associated with leflunomide treatment |
| JOP20190207A1 (ar) | 2017-03-14 | 2019-09-10 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على بونيسيمود |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK54063C (da) * | 1935-02-22 | 1937-12-27 | Hoffmann La Roche | Fremgangsmaade til Fremstilling af dialkylsubstituerede Amider af Isoksazolkarbonsyrer. |
| DE634286C (de) * | 1935-02-23 | 1936-08-26 | Hoffmann La Roche & Co Akt Ges | Verfahren zur Herstellung dialkylsubstituierter Amide von Isoxazolcarbonsaeuren |
| US2126329A (en) * | 1936-03-20 | 1938-08-09 | Hoffmann La Roche | Amide derivatives of isoxazole carboxylic acids |
| DE673111C (de) * | 1938-01-18 | 1939-03-16 | Hoffmann La Roche & Co Akt Ges | Verfahren zur Darstellung amidartiger Abkoemmlinge von Homologen der Isoxazolcarbonsaeuren |
| DK58903C (da) * | 1940-02-27 | 1941-08-04 | Hoffmann La Roche | Fremgangsmaade til Fremstilling af substituerede Amider af 3,5-Dimetyl-isoksazol-karbonsyre-(4). |
| US2288863A (en) * | 1940-02-27 | 1942-07-07 | Hoffmann La Roche | Process for the manufacture of substituted amides of 3,5-dimethylisoxazole-4-carboxylic acid |
-
1976
- 1976-05-31 ES ES448386A patent/ES448386A1/es not_active Expired
- 1976-05-31 NL NLAANVRAGE7605841,A patent/NL178596C/xx not_active IP Right Cessation
- 1976-06-02 CH CH696276A patent/CH603608A5/xx not_active IP Right Cessation
- 1976-06-03 IT IT23923/76A patent/IT1063592B/it active
- 1976-06-03 US US05/692,306 patent/US4087535A/en not_active Expired - Lifetime
- 1976-06-03 LU LU75077A patent/LU75077A1/xx unknown
- 1976-06-04 FR FR7617038A patent/FR2313052A1/fr active Granted
- 1976-06-04 JP JP51065476A patent/JPS5938230B2/ja not_active Expired
- 1976-06-04 DK DK248376A patent/DK151013C/da not_active IP Right Cessation
- 1976-06-04 CA CA254,134A patent/CA1076584A/en not_active Expired
- 1976-06-04 GB GB23185/76A patent/GB1547452A/en not_active Expired
- 1976-06-04 AT AT413776A patent/AT349007B/de not_active IP Right Cessation
- 1976-06-04 IE IE1202/76A patent/IE43136B1/en unknown
- 1976-06-04 MX MX000270U patent/MX3144E/es unknown
- 1976-06-08 BE BE167707A patent/BE842689A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US4087535A (en) | 1978-05-02 |
| ES448386A1 (es) | 1978-04-16 |
| MX3144E (es) | 1980-05-09 |
| FR2313052A1 (fr) | 1976-12-31 |
| BE842689A (fr) | 1976-12-08 |
| FR2313052B1 (da) | 1979-09-28 |
| IE43136L (en) | 1976-12-05 |
| CH603608A5 (da) | 1978-08-31 |
| LU75077A1 (da) | 1977-03-09 |
| GB1547452A (en) | 1979-06-20 |
| DK151013C (da) | 1988-03-07 |
| IE43136B1 (en) | 1980-12-31 |
| NL178596C (nl) | 1986-04-16 |
| JPS5938230B2 (ja) | 1984-09-14 |
| AT349007B (de) | 1979-03-12 |
| NL7605841A (nl) | 1976-12-07 |
| CA1076584A (en) | 1980-04-29 |
| ATA413776A (de) | 1978-08-15 |
| DK151013B (da) | 1987-10-12 |
| JPS527960A (en) | 1977-01-21 |
| IT1063592B (it) | 1985-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK248376A (da) | Isoxazolderivater samt deres fremstilling og anvendelse | |
| DK571476A (da) | Indolderivater deres fremstilling og anvendelse | |
| DK56876A (da) | Prostaglandinanaloge samt deres fremstilling og anvendelse | |
| DK164175A (da) | Thienyl- og thietylurinstofderivater samt deres fremstilling og anvendelse | |
| DK211775A (da) | Substituerede phenylguanidiner samt deres fremstilling og anvendelse | |
| DK571376A (da) | Indolderivater deres fremstilling og anvendelse | |
| DK287476A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK286676A (da) | Bicycloheptenforbindelser samt deres fremstilling og anvendelse | |
| DK174776A (da) | 1,1,1-triaryl-alkylaminer samt deres fremstilling og anvendelse | |
| DK581075A (da) | Prostaglandinanaloge samt deres fremstilling og anvendelse | |
| DK353575A (da) | 1-thiadiazolylimidazolidinoner samt deres fremstilling og anvendelse | |
| DK340475A (da) | Thiazolidinderivater samt deres fremstilling og anvendelse | |
| DK496775A (da) | Prostaglandinpyrrolidoner samt deres fremstilling og anvendelse | |
| DK457275A (da) | Derivater af fragmentet b af difteritoxinet samt deres fremstilling og anvendelse | |
| DK554776A (da) | Prostaglandinanaloge pyrrolidoner samt deres fremstilling og anvendelse | |
| DK2476A (da) | Morpholinderivater og deres fremstilling | |
| DK281476A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK464176A (da) | Cycloalkanpyrazoler samt deres fremstilling og anvendelse | |
| DK426376A (da) | 4-hydroxymethyl-2-pyrrolidinoner samt deres fremstilling og anvendelse | |
| DK279777A (da) | Carbostyriler samt deres fremstilling og anvendelse | |
| DK523176A (da) | Substituerede tetraalkylpiperidin-4-oximer deres fremstilling og anvendelse | |
| DK574976A (da) | Substituerede cycloalkanpyrazoler samt deres fremstilling og anvendelse | |
| DK189876A (da) | Sulfamylbenzoesyrer samt deres fremstilling og anvendelse | |
| DK586775A (da) | Pyridazinderivater samt deres fremstilling og anvendelse | |
| DK307776A (da) | Morpholinderivater og deres fremstilling |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |